Abbott India Limited ABBOTINDIA.BO
ABBOTINDIA.BO
Abbott India Limited ALKEM.NS
Alkem Laboratories Limited ALKEM.BO
Alkem Laboratories Limited AUROPHARMA.BO
Aurobindo Pharma Limited AUROPHARMA.NS
Aurobindo Pharma Limited GLAXO.BO
GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS
GlaxoSmithKline Pharmaceuticals Limited GLENMARK.BO
Glenmark Pharmaceuticals Limited GLENMARK.NS
Glenmark Pharmaceuticals Limited GLAND.BO
Gland Pharma Limited
Abbott India Limited ALKEM.NS
Alkem Laboratories Limited ALKEM.BO
Alkem Laboratories Limited AUROPHARMA.BO
Aurobindo Pharma Limited AUROPHARMA.NS
Aurobindo Pharma Limited GLAXO.BO
GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS
GlaxoSmithKline Pharmaceuticals Limited GLENMARK.BO
Glenmark Pharmaceuticals Limited GLENMARK.NS
Glenmark Pharmaceuticals Limited GLAND.BO
Gland Pharma Limited
Performance
| Periode | ABBOTINDIA.BO | ALKEM.NS | ALKEM.BO | AUROPHARMA.BO | AUROPHARMA.NS | GLAXO.BO | GLAXO.NS | GLENMARK.BO | GLENMARK.NS | GLAND.BO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -0.33 % | 6.68 % | 5.94 % | -13.98 % | -13.72 % | -5.72 % | -5.43 % | 27.60 % | 28.02 % | 31.84 % |
| YTD | -0.28 % | -0.40 % | -0.79 % | -19.95 % | -19.81 % | 23.09 % | 23.55 % | 12.41 % | 12.67 % | 6.75 % |
| 1Y | 4.58 % | -6.92 % | -7.15 % | -24.96 % | -24.75 % | 5.02 % | 5.34 % | 8.43 % | 8.63 % | 17.74 % |
| 3Y | 63.03 % | 78.71 % | 78.49 % | 106.32 % | 106.90 % | 100.24 % | 100.81 % | 355.45 % | 357.15 % | -11.77 % |
| 5Y | 91.86 % | 113.73 % | 113.08 % | 37.88 % | 38.29 % | 83.42 % | 84.92 % | 279.76 % | 280.70 % | 6.13 % |
| 10Y | 440.43 % | 301.57 % | 300.27 % | 30.13 % | 30.32 % | 67.78 % | 67.22 % | 79.78 % | 80.62 % | 6.13 % |
| From the beginning | 3 691.49 % | 301.57 % | 300.27 % | 2 577.85 % | 5 167.96 % | 596.91 % | 796.85 % | 8 668.97 % | 6 607.23 % | 6.13 % |